Stay updated with breaking news from Supercon Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bruker Co. (NASDAQ:BRKR – Get Rating) CEO Frank H. Laukien sold 82,795 shares of the stock in a transaction on Monday, May 1st. The shares were sold at an average price of $78.75, for a total transaction of $6,520,106.25. Following the completion of the transaction, the chief executive officer now owns 38,262,287 shares of the […]
Bruker (NASDAQ:BRKR – Get Rating) posted its earnings results on Thursday. The medical research company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.09, Briefing.com reports. Bruker had a return on equity of 34.13% and a net margin of 11.72%. The firm had revenue of $685.30 million for the quarter, […]
Q1 2023 revenues of $685.3 million, up 15.2% year-over-year ; organic revenue up 17.6% yoy Q1 2023 GAAP EPS $0.52; non-GAAP EPS $0.64, up 30.6% yoy Bruker increases FY 2023 guidance for... | May 4, 2023
Bruker (NASDAQ:BRKR – Get Rating) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday. A number of other research analysts also recently commented on BRKR. The Goldman Sachs Group lifted their price objective on shares of Bruker from $63.00 to $70.00 […]
Duality Advisers LP purchased a new stake in Bruker Co. (NASDAQ:BRKR – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm purchased 33,775 shares of the medical research company’s stock, valued at approximately $2,309,000. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wipfli […]